Finance

Beta
Lists
AJG:NYSE
Arthur J. Gallagher & Co.
$224.76
+3.15%
(+6.85) 1D
Jun 26, 11:38:26 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AJG...
Open
$220.58
High
$225.60
Low
$219.66
Mkt. cap
58.44B
Avg. vol.
1.90M
Volume
359.07K
Dividend
1.25%
Quarterly dividend
$0.70
Ex-dividend date
Jun 5, 2026
P/E ratio
35.97
52-wk high
$323.25
52-wk low
$190.75
EPS
$6.25
Beta
0.52
Shares outstanding
256.90M
No. of employees
72K
Open
$220.58
High
$225.60
Low
$219.66
Mkt. cap
58.44B
Avg. vol.
1.90M
Volume
359.07K
Dividend
1.25%
Quarterly dividend
$0.70
Ex-dividend date
Jun 5, 2026
P/E ratio
35.97
52-wk high
$323.25
52-wk low
$190.75
EPS
$6.25
Beta
0.52
Shares outstanding
256.90M
No. of employees
72K
News stories
From sources across the web
Profile
Arthur J. Gallagher & Co. is an American insurance brokerage and risk management services company based in Rolling Meadows, Illinois, a suburb of Chicago. The company provides insurance brokerage services and risk management services, the latter of which primarily includes the processing of workers compensation and automobile insurance claims through the company's adjusters. The company is ranked 367th on the Fortune 500 and 192nd on the Forbes Global 2000. Founded in 1927, the company ranks among the world's largest insurance brokers. Wikipedia
About Arthur J. Gallagher & Co.
CEOJ. Patrick Gallagher Jr
Employees72K
Founded1927
HeadquartersRolling Meadows, Illinois, United States
SectorInsurance
Websiteajg.com
Analyst ratings
Based on 18 analysts giving stock ratings to AJG in the past 3 months
Buy
Buy
13
Hold
5
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for AJG in the last 3 months.
Highest
Current $224.76
$388.00 (+72.62%)
Average
$260.47 (+15.89%)
Lowest
$206.00 (-8.35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alex Scott
Barclays
Buy
Maintained
$275.00
+22.4%
06/22/2026
Gregory Peters
Raymond James
Hold
Maintained
-
-
06/18/2026
Andrew Andersen
Jefferies
Buy
Reiterated
$265.00
+17.9%
06/18/2026
Robert Cox CFA
Goldman Sachs
Buy
Maintained
$242.00
+7.7%
06/17/2026
Michael Zaremski
BMO Capital
Buy
Reiterated
$265.00
+17.9%
06/18/2026
Andrew Kligerman
TD Cowen
Buy
Reiterated
$388.00
+72.6%
06/18/2026
Brian Meredith
UBS
Buy
Reiterated
$250.00
+11.2%
06/18/2026
Mark Hughes
Truist Financial
Hold
Maintained
$225.00
+0.1%
06/18/2026
Meyer Shields
KBW
Hold
Maintained
$242.00
+7.7%
06/18/2026
Elyse Greenspan
Wells Fargo
Buy
Reiterated
$271.00
+20.6%
06/18/2026
David Motemaden
Evercore ISI
Buy
Maintained
$295.00
+31.2%
06/17/2026
Rowland Mayor
RBC Capital
Buy
Maintained
$260.00
+15.7%
06/17/2026
Bob Huang
Morgan Stanley
Buy
Maintained
$240.00
+6.8%
05/21/2026
Matthew Heimermann
Citi
Buy
Upgraded
$250.00
+11.2%
05/06/2026
Ryan Tunis
Cantor Fitzgerald
Hold
Maintained
$282.00
+25.5%
04/30/2026
Adam Klauber
William Blair
Buy
Maintained
$206.00
-8.3%
05/01/2026
Yaron Kinar
Mizuho Securities
Buy
Maintained
$261.00
+16.1%
05/01/2026
Paul Newsome
Piper Sandler
Hold
Maintained
$211.00
-6.1%
05/01/2026
Unknown Analyst
TD Cowen
Buy
Reiterated
$388.00
+72.6%
03/18/2026
Cave Montazeri
Deutsche Bank
Buy
Maintained
$280.00
+24.6%
02/26/2026
Unknown Analyst
Jefferies
Hold
Maintained
$280.00
+24.6%
02/02/2026
Tracy Benguigui
Wolfe Research
Buy
Reiterated
$289.00
+28.6%
01/29/2026
Last report
Apr 30, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$4.47 / $4.43
+0.98%beat
Revenue / Est. (USD)
4.63B / 4.77B
-2.84%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.95B
3.16B
3.46B
4.63B
Cost of goods sold
1.69B
1.83B
2.18B
2.40B
Cost of revenue
1.69B
1.83B
2.18B
2.40B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
495.60M
512.50M
580.30M
579.00M
Operating expense
726.40M
786.40M
918.80M
917.00M
Total operating expenses
2.42B
2.61B
3.10B
3.32B
Operating income
527.20M
543.60M
361.60M
1.32B
Other non operating income
-
-
-
-
EBT including unusual items
471.40M
346.90M
180.00M
1.04B
EBT excluding unusual items
601.10M
549.90M
322.20M
1.24B
Income tax expense
105.20M
73.30M
25.70M
220.00M
Effective tax rate
22.32%
21.13%
14.28%
21.09%
Other operating expenses
-
-
-
-
Net income
365.80M
272.70M
151.10M
822.00M
Net profit margin
12.42%
8.63%
4.36%
17.75%
Earnings per share
2.33
2.32
2.38
4.47
Interest and investment income
232.50M
167.10M
121.80M
86.00M
Interest expense
-158.60M
-160.80M
-161.20M
-158.00M
Net interest expenses
73.90M
6.30M
-39.40M
-72.00M
Depreciation and amortization charges
49.70M
54.10M
58.10M
61.00M
EBITDA
758.00M
817.50M
700.10M
1.65B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of AJG
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer